Shield Therapeutics plc Stock OTC Markets
Stocks
SHIEF
GB00BYV81293
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
12:37:09 2026-08-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.0704 USD | +26.16% |
|
+26.16% | -51.78% |
| 07-31 | WINNERS & LOSERS: NARF has contract cancelled; Headlam reviews options | AN |
| 07-30 | EARNINGS AND TRADING: Zoo Digital revenue falls but loss narrows | AN |
| Market Cap | 47.08M 63.82M 55.09M 51.69M 88.52M 6.1B 89.75M 606M 237M 3.06B 240M 234M 10.17B | P/E 2026 * |
-200x | P/E 2027 * | 5.96x |
|---|---|---|---|---|---|
| Enterprise Value | 65.4M 88.65M 76.53M 71.8M 123M 8.48B 125M 842M 330M 4.25B 333M 326M 14.13B | EV / Sales 2026 * |
1.16x | EV / Sales 2027 * | 0.77x |
| Free-Float |
38.25% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Shield Therapeutics plc
| 1 day | +26.16% | ||
| 1 week | +26.16% | ||
| Current month | +21.38% | ||
| 1 month | -11.22% | ||
| 3 months | -41.38% | ||
| 6 months | -52.77% | ||
| Current year | -51.78% |
| 1 month | 0.05 |  | 0.08 |
| Current year | 0.05 | | 0.17 |
| 1 year | 0.05 | | 0.17 |
| 3 years | 0.01 | | 0.17 |
| 5 years | 0.01 | | 0.64 |
| 10 years | 0.01 | | 2.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Karl Lundström
CEO | Chief Executive Officer | 64 | 2024-07-23 |
Stephanie Hicks
IRC | Investor Relations Contact | - | - |
| General Counsel | - | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 68 | 2016-01-31 | |
| Chairman | 70 | 2020-06-17 | |
| Director/Board Member | 59 | 2020-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +26.16% | +26.16% | - | - | 63.82M | |
| +0.30% | -0.26% | +38.86% | +1.15% | 80.48B | |
| -1.02% | -1.34% | -2.54% | +30.42% | 50.63B | |
| -0.23% | -5.04% | +9.90% | +166.83% | 47.57B | |
| +17.25% | +14.09% | -41.83% | -41.67% | 45.84B | |
| -0.32% | +0.98% | +50.90% | -20.02% | 30.9B | |
| +1.80% | +7.77% | +130.05% | -39.33% | 25.73B | |
| +2.78% | +1.60% | +42.08% | +92.34% | 25.03B | |
| +1.36% | +1.15% | -5.15% | +207.31% | 21.16B | |
| +1.22% | +4.98% | +64.91% | +126.71% | 16.75B | |
| Average | +4.44% | +0.46% | +31.91% | +58.19% | 38.23B | |
| Weighted average by Cap. | +2.27% | -0.10% | +24.71% | +43.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.28M 76.29M 65.86M 61.79M 106M 7.29B 107M 724M 284M 3.65B 286M 280M 12.16B | 75.86M 103M 88.78M 83.29M 143M 9.83B 145M 976M 383M 4.93B 386M 378M 16.39B |
| Net income | -72.5K -98.28K -84.85K -79.6K -136K -9.4M -138K -933K -366K -4.71M -369K -361K -15.66M | 7.86M 10.65M 9.2M 8.63M 14.78M 1.02B 14.98M 101M 39.64M 510M 40M 39.13M 1.7B |
| Net Debt | 18.32M 24.84M 21.44M 20.12M 34.45M 2.37B 34.93M 236M 92.41M 1.19B 93.25M 91.23M 3.96B | 11.13M 15.09M 13.03M 12.22M 20.93M 1.44B 21.22M 143M 56.15M 723M 56.66M 55.43M 2.4B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- STX Stock
- SHIEF Stock
Select your edition
All financial news and data tailored to specific country editions
